JUL 12, 2020 10:17 AM PDT

Lung Cancer is Different in Non-Smokers

WRITTEN BY: Carmen Leitch

Not everyone that gets lung cancer is a current or former smoker, and researchers have now found that lung cancer is different and distinct in non-smokers, who are also more likely to have different responses to lung cancer treatments. These conclusions come from a study that assessed people in Taiwan with high lung cancer rates in non-smokers. The study, which was reported in Cell, identified genetic damage from carcinogens in the environment. The genetic changes varied according to age and sex, and one change that aggressively promotes cancer was found in young women.

Image credit: Peakpx

"We carried out the most comprehensive study ever conducted into the biology of lung cancers in an East-Asian population with a high proportion of non-smokers, and found that their disease is molecularly diverse and distinct from what we classically see in smokers," said Dr. Jyoti Choudhary, Team Leader in Functional Proteomics at The Institute of Cancer Research, London. "We found distinct patterns of genetic faults in non-smokers and between women and men, which suggest that a woman who has never smoked, for example, is likely to respond differently to treatment than a male smoker.

"Some early-stage lung tumors had molecular features that are much more like that typically seen in later-stage disease - which could help us more accurately diagnose patients with aggressive disease, and inform treatment strategies."

In this work, the researchers used 103 lung tumor samples from lung cancer patients, including many non-smokers, to analyze the genetics and proteomics of cancer cells. Some early-stage tumors had biological similarities to advanced-stage tumors taken from smokers. Women's tumors often had mutations in a gene that is known to be associated with lung cancer called EGFR, while in men the cancer-associated mutations were found in the genes KRAS and APC, also known to be linked to cancer.

The study can help inform treatment approaches for men and women and smokers and non-smokers. People that have late-stage-like tumors might be monitored differently and given a different therapeutic regimen, for example.

"This new study offers a deep dive into the biology of lung cancer in people who have never smoked. It reveals new ways of telling apart patients with different tumor characteristics that could be exploited with tailored treatment strategies," said Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London.

The researchers also identified a pattern of changes in the APOBEC gene family in a majority of female patients younger than 60, who did not carry EGFR mutations. APOBEC genes are involved in immune function but can also be used by cancerous cells to encourage drug resistance. Immunotherapy tends to be more effective in people who don't carry EGFR mutations. There was also a mutational pattern that was found in older women and was linked to environmental carcinogens like pollution.

"In order to beat cancer, we need to understand all the ways it can develop. This research highlights just how much cancers can vary between people depending on their lifestyle and environment. Understanding the difference between lung cancers in smokers and non-smokers could be vital for providing patients with the most appropriate treatment," said Dr. Emily Armstrong, research information manager at Cancer Research UK.

Sources: AAAS/Eurekalert! via Institute of Cancer Research, Cell

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 18, 2021
Genetics & Genomics
How DNA Has Told Stories of Human History
JUN 18, 2021
How DNA Has Told Stories of Human History
Archeological digs have told us a lot about human history, but genetic tools have been able to fill in some of the gaps ...
JUN 20, 2021
Genetics & Genomics
Revealing Epigenetic Causes of Type 1 Diabetes
JUN 20, 2021
Revealing Epigenetic Causes of Type 1 Diabetes
Our bodies have to regulate the level of glucose, or sugar, in the blood. The hormone insulin, produced by beta cells in ...
JUL 05, 2021
Cell & Molecular Biology
A Step Toward Artificial Chromosomes - Manufacturing a Kinetochore
JUL 05, 2021
A Step Toward Artificial Chromosomes - Manufacturing a Kinetochore
In human cells, lengthy strands of DNA have to be carefully organized and compacted so they'll fit into the nucleus; our ...
JUL 19, 2021
Microbiology
Engineering a Virus Trap
JUL 19, 2021
Engineering a Virus Trap
Viral infections are difficult to treat - antibiotics only work against bacteria - and there are few effective antibodie ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 01, 2021
Genetics & Genomics
Rethinking the Cause of Mutations That Lead to Melanoma
AUG 01, 2021
Rethinking the Cause of Mutations That Lead to Melanoma
Throughout our lives, new cells often replace the ones that become damaged or worn out. As cells divide, they have to re ...
Loading Comments...